European shares rebound from Omicron-fuelled selloff



(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

Nov 29 (Reuters) - European shares rebounded on Monday from their worst selloff in more than a year, as investors awaited clues on whether the Omicron variant of coronavirus would hamper economic recoveries and monetary tightening plans by central banks.

The pan-European STOXX 600 .STOXX advanced 1% as of 0818 GMT, after a 3.7% slump on Friday, triggered by concerns around the newly discovered variant.

A South African doctor who was one of the first to suspect a different coronavirus strain among patients said on Sunday that symptoms of the Omicron variant were so far mild and could be treated at home.

All sectors were trading higher, with travel stocks .SXTP leading gains as Airbus AIR.PA , Lufthansa LHAG.DE and Ryanair RYA.I rose between 0.7% and 1.7% after slumping the most on Friday on fears of fresh travel restrictions.

Oil stocks .SXEP also lifted the benchmark, adding 1.8% as crude prices recovered on speculation that OPEC+ may pause an output increase in response to the spread of Omicron.

Meanwhile, European Central Bank board member Isabel Schnabel said inflation peaked in November and it would be premature to tighten policy.

BT Group BT.L jumped 7.7% on reports that Indian oil-to-telecom conglomerate Reliance RELI.NS was considering an offer for the UK telecom firm.

Car parts group Faurecia EPED.PA dropped 5.6% after trimming its full-year guidance, citing a drop in European automotive production.
Reporting by Anisha Sircar in Bengaluru; Editing by Arun Koyyur

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明